GlassScriptPhysician profile
Patrick S Rheaume
NPI 1306009170
$1,196.35
in general payments reported to CMS, 2019-2025
15 companies · $78.12 in 2025
The $78.12 reported for 2025 was less than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $213 · 2020: $59.05 · 2021: $99.80 · 2022: $681 · 2023: $23.72 · 2024: $41.27 · 2025: $78.12.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $143.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $143.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acessa Health INC. | $639.94 | 2022 | |
| Abbvie INC. | $145.71 | 2019-2021 | |
| Hologic Sales and Service, LLC | $120.58 | 2019-2025 | Acessa Provu System |
| Bayer Healthcare Pharmaceuticals INC. | $38.34 | 2019-2021 | |
| Biogen, INC. | $33.04 | 2025 | Zurzuvae |
| Coopersurgical, INC. | $32.65 | 2019-2024 | Paragard T 380a |
| Allergan, INC. | $31.66 | 2019 | |
| Exeltis, USA INC. | $28.34 | 2019-2021 | |
| Ethicon US, LLC | $27.23 | 2022 | |
| Dexcom, INC. | $23.72 | 2023 | Dexcom G6 Transmitter |
| Sumitomo Pharma America, INC. | $17.92 | 2025 | Myfembree |
| Therapeuticsmd, INC. | $16.57 | 2019 | |
| Lupin INC. | $14.71 | 2021 | |
| Baudax Bio INC. | $13.88 | 2022 | |
| Mission Pharmacal Company | $12.06 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Rheaume listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.